Results of radiation treatment for bladder cancer that has not spread
Looks at radiation, with or without chemotherapy, in people with bladder cancer.
Plain-language title generated from the registry record
Registry title: Outcomes of Definitive Radiotherapy for Bladder Cancer
Key facts
- Where
- Sohag, EgyptSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study looks at people with bladder cancer that has not spread, who get radiotherapy meant to remove all of the disease, with or without a drug that makes radiotherapy work better.
- Sex
- Men and women can join.
- Disease stage
- Bladder cancer (urothelial carcinoma or its variants) confirmed under the microscope. Radiotherapy given with the aim of removing all of the disease. The cancer has not spread to other parts of the body.
- Earlier treatment
- People who had the bladder removed (radical cystectomy) cannot join.
Main reasons for not taking part
- Radiotherapy given only to ease symptoms
- Bladder already removed by surgery (radical cystectomy)
- Follow-up data are incomplete
Read by machine on 13 November 2026.
Where in Egypt
- Sohag university hospitalsSohag, EgyptContact: heba elsagheerNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Sohag University
- Trial code
- NCT07503795
- Record updated
- 31 March 2026
- Original description
this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizerRead full original descriptionShow less
Outcomes of Definitive Radiotherapy for Bladder Cancer: Real-World Experience From a Single Center
this is an observational study for patients with non metastatic bladder cancer recieving local radical radiotherapy with curative intent recieving radical dose of radiotherapy with or without chemosensitizer
Inclusion: Histologically confirmed urothelial carcinoma or variants; definitive intent radiotherapy.
Exclusion: Palliative radiotherapy only; prior radical cystectomy; or incomplete follow-up data.